Conference Programs

MON AUG 22 & TUES AM, AUG 23

TUES PM, AUG 23 & WED, AUG 24

MON PM, AUG 22 & TUES, AUG 23

Enabling Point-of-Care Diagnostics

TUES PM, AUG 23 & WED, AUG 24

Advanced Diagnostics for Infectious Disease

MON PM, AUG 22 & TUES, AUG 23

Drug-Diagnostic Co-Development and Companion Diagnostics

TUES PM, AUG 23 & WED, AUG 24

Coverage and Reimbursement for Advanced Diagnostics

Early Detection and Liquid Biopsy Stream

TUES PM, AUG 23 & WED, AUG 24

Liquid Biopsy for Disease Management

MON PM, AUG 22 & TUES, AUG 23

Early Cancer Surveillance

2022 PLENARY PANEL DISCUSSIONS

Legislative Efforts to Modernize Diagnostic Oversight

Cynthia A. Bens

MODERATOR:
Cynthia A. Bens
Senior Vice President, Public Policy, Personalized Medicine Coalition

Jeff Allen, PhD

Jeff Allen, PhD
President and CEO, Friends of Cancer Research

Sarah Thibault-Sennett, PhD

Sarah Thibault-Sennett, PhD
Director, Public Policy & Advocacy, Association for Molecular Pathology

Lauren R. Silvis, PhD

Lauren R. Silvis, PhD
Senior Vice President, External Affairs, Tempus, Inc.

Susan Van Meter

Susan Van Meter
President, American Clinical Laboratory Association

Zach Rothstein, PhD

Zach Rothstein, PhD
Executive Director, AdvaMedDx, and Senior Vice President, Technology & Regulatory Affairs, AdvaMed

Self-Testing: What We Have Learned from the Pandemic for Future Applications

Franklin R. Cockerill III, MD

MODERATOR:
Franklin R. Cockerill III, MD
Founding Partner, Trusted Health Advisors; Adjunct Professor, Medicine, Rush University

Karen A. Heichman, PhD

Karen A. Heichman, PhD
Deputy Director, Bill & Melinda Gates Foundation

Jack Jeng, MD, MBA

Jack Jeng, MD, MBA
CMO, Hone Health

Elizabeth M. Marlowe, PhD

Elizabeth M. Marlowe, PhD, D(ABMM)
Senior Scientific Director, Head R&D Infectious Diseases & Immunology, Quest Diagnostics Nichols Institute

Raquel M Martinez, PhD

Raquel M Martinez, PhD
Director, System & Core Lab, Clinical & Molecular Microbiology, Geisinger Health System

Nicole Zitterkopf, PhD

Nicole Zitterkopf, PhD, D(ABMM), MPH, MT(ASCP)
Vice President Laboratory, Service Line Advancement Team, OptumHealth

View All 2022 Speakers

Welcome to the 2022 Next Generation Dx Summit

Advancing Diagnostics Together

We are proud to host Cambridge Healthtech Institute's Fourteenth Annual Next Generation Dx Summit which will take place in-person at the Grand Hyatt Washington, D.C. on August 22-24. The Next Generation Dx Summit is the nexus for key opinion leaders across the world to share recent progress in diagnostic advancement and technology innovation. The event provides a valuable window on how point-of-care, infectious disease, liquid biopsy and companion diagnostics are changing the standard of care. Now in its fourteenth year, the Next Generation Dx Summit is a must-attend event with complete coverage of the most timely and important topics for the industry.

View Event At-A-Glance

Benefits of attending include:

Form partnerships with major players in the evolving areas of diagnostics
Gain a comprehensive, up-to-date view of diagnostics, including the latest rapid and molecular diagnostics for COVID-19
Gather important industry announcements
Hear late-breaking news on lessons learned from COVID-19 testing
Review innovative products and novel platforms and technologies in the exhibit hall and the poster session